- About this Journal ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 898327, 9 pages
Symptom Distress Associated with Biopsy in Women with Suspect Breast Lesions
1University Connecticut Health Center, 10 Talcott Notch Road, East Lobby, 3rd Floor, Farmington, CT 06030, USA
2The Carol and Ray Neag Comprehensive Cancer center, University of Connecticut School of Medicine, Farmington, CT 06030, USA
3Department of Psychology, University of Connecticut, Storrs, CT 06269, USA
Received 1 May 2012; Accepted 22 May 2012
Academic Editors: J. Klijanienko and A. E. Pinto
Copyright © 2012 Jayesh Kamath et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- American Cancer Society, Cancer Statistics, http://www.cancer.org/docroot/PRO/content/PRO_1_1_Cancer_Statistics_2009_Presentation.asp, 2009.
- J. Brett, C. Bankhead, B. Henderson, E. Watson, and J. Austoker, “The psychological impact of mammographic screening. A systematic review,” Psycho-Oncology, vol. 14, no. 11, pp. 917–938, 2005.
- N. T. Brewer, T. Salz, and S. E. Lillie, “Systematic review: the long-term effects of false-positive mammograms,” Annals of Internal Medicine, vol. 146, no. 7, pp. 502–510, 2007.
- US Preventive Services Task Force, “Screening for breast cancer: U.S. preventive services task force recommendation statement,” Annals of Internal Medicine, vol. 151, no. 10, pp. 716–726, 2009.
- I. M. Lipkus, S. Halabi, T. S. Strigo, and B. K. Rimer, “The impact of abnormal mammograms on psychosocial outcomes and subsequent screening,” Psycho-Oncology, vol. 9, no. 5, pp. 402–410, 2000.
- A. R. Aro, S. Pilvikki Absetz, T. M. van Elderen, E. van der Ploeg, and L. J. T. van der Kamp, “False-positive findings in mammography screening induces short-term distress—breast cancer-specific concern prevails longer,” European Journal of Cancer, vol. 36, no. 9, pp. 1089–1097, 2000.
- E. D. Pisano, J. Earp, M. Schell, K. Vokaty, and A. Denham, “Screening behavior of women after a false-positive mammogram,” Radiology, vol. 208, no. 1, pp. 245–249, 1998.
- J. Brett, J. Austoker, and G. Ong, “Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment,” Journal of Public Health Medicine, vol. 20, no. 4, pp. 396–403, 1998.
- M. Montgomery, “Uncertainty during breast diagnostic evaluation: state of the science,” Oncology Nursing Forum, vol. 37, no. 1, pp. 77–83, 2010.
- M. T. Hegel, C. P. Moore, E. D. Collins et al., “Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer,” Cancer, vol. 107, no. 12, pp. 2924–2931, 2006.
- Y. Iwamitsu, K. Shimoda, H. Abe, T. Tani, M. Okawa, and R. Buck, “Anxiety, emotional suppression, and psychological distress before and after breast cancer diagnosis,” Psychosomatics, vol. 46, no. 1, pp. 19–24, 2005.
- A. L. Stanton and P. R. Snider, “Coping with a breast cancer diagnosis: a prospective study,” Health Psychology, vol. 12, no. 1, pp. 16–23, 1993.
- K. A. Deane and L. F. Gegner, “Information needs, uncertainty, and anxiety in women who had a breast biopsy with benign outcome,” Cancer Nursing, vol. 21, no. 2, pp. 117–126, 1998.
- M. A. Andrykowski, J. S. Carpenter, J. L. Studts et al., “Psychological impact of benign breast biopsy: a longitudinal, comparative study,” Health Psychology, vol. 21, no. 5, pp. 485–494, 2002.
- J. V. Pasacreta, “Depressive phenomena, physical symptom distress, and functional status among women with breast,” Nursing Research, vol. 46, no. 4, pp. 214–221, 1997.
- G. H. Montgomery, J. B. Schnur, J. Erblich, M. A. Diefenbach, and D. H. Bovbjerg, “Presurgery psychological factors predict pain, nausea, and fatigue one week after breast cancer surgery,” Journal of Pain and Symptom Management, vol. 39, no. 6, pp. 1043–1052, 2010.
- W. W. T. Lam, R. Fielding, and E. Y. Y. Ho, “Predicting psychological morbidity in Chinese women after surgery for breast carcinoma,” Cancer, vol. 103, no. 3, pp. 637–646, 2005.
- W. W. T. Lam, G. A. Bonanno, A. D. Mancini et al., “Trajectories of psychological distress among Chinese women diagnosed with breast cancer,” Psycho-Oncology, vol. 19, no. 10, pp. 1044–1051, 2010.
- D. W. Kissane, D. M. Clarke, J. Ikin et al., “Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey,” Medical Journal of Australia, vol. 169, no. 4, pp. 192–196, 1998.
- C. S. Cleeland, “Symptom burden: multiple symptoms and their impact as patient-reported outcomes,” Journal of the National Cancer Institute, no. 37, pp. 16–21, 2007.
- A. B. Kornblith, J. E. Herndon, R. B. Weiss et al., “Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy,” Cancer, vol. 98, no. 4, pp. 679–689, 2003.
- L. M. Thornton, B. L. Andersen, and W. P. Blakely, “The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system,” Health Psychology, vol. 29, no. 3, pp. 333–337, 2010.
- L. J. Luecken and B. E. Compas, “Stress, coping, and immune function in breast cancer,” Annals of Behavioral Medicine, vol. 24, no. 4, pp. 336–344, 2002.
- J. E. Bower, P. A. Ganz, N. Aziz, and J. L. Fahey, “Fatigue and proinflammatory cytokine activity in breast cancer survivors,” Psychosomatic Medicine, vol. 64, no. 4, pp. 604–611, 2002.
- H. Soygur, O. Palaoglu, E. S. Akarsu et al., “Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 31, no. 6, pp. 1242–1247, 2007.
- T. R. Mendoza, X. S. Wang, C. S. Cleeland et al., “The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory,” Cancer, vol. 85, no. 5, pp. 1186–1196, 1999.
- Y. J. Chang, J. S. Lee, C. G. Lee et al., “Assessment of clinical relevant fatigue level in cancer,” Supportive Care in Cancer, vol. 15, no. 7, pp. 891–896, 2007.
- A. S. Zigmond and R. P. Snaith, “The hospital anxiety and depression scale,” Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361–370, 1983.
- I. Bjelland, A. A. Dahl, T. T. Haug, and D. Neckelmann, “The validity of the Hospital Anxiety and Depression Scale: an updated literature review,” Journal of Psychosomatic Research, vol. 52, no. 2, pp. 69–77, 2002.
- A. J. Mitchell, N. Meader, and P. Symonds, “Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis,” Journal of Affective Disorders, vol. 126, no. 3, pp. 335–348, 2010.
- D. J. Buysse, C. F. Reynolds, T. H. Monk, S. R. Berman, and D. J. Kupfer, “The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research,” Psychiatry Research, vol. 28, no. 2, pp. 193–213, 1989.
- J. S. Carpenter and M. A. Andrykowski, “Psychometric evaluation of the Pittsburgh Sleep Quality Index,” Journal of Psychosomatic Research, vol. 45, no. 1, pp. 5–13, 1998.
- N. K. Aaronson, S. Ahmedzai, B. Bergman et al., “The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology,” Journal of the National Cancer Institute, vol. 85, no. 5, pp. 365–376, 1993.
- H. E. Niezgoda and J. L. Pater, “A validation study of the domains of the core EORTC quality of life questionnaire,” Quality of Life Research, vol. 2, no. 5, pp. 319–325, 1993.
- D. Osoba, B. Zee, J. Pater, D. Warr, L. Kaizer, and J. Latreille, “Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer,” Quality of Life Research, vol. 3, no. 5, pp. 353–364, 1994.
- D. Watson, L. A. Clark, and A. Tellegen, “Development and validation of brief measures of positive and negative affect: the PANAS scales,” Journal of Personality and Social Psychology, vol. 54, no. 6, pp. 1063–1070, 1988.
- J. R. Crawford and J. D. Henry, “The Positive and Negative Affect Schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample,” British Journal of Clinical Psychology, vol. 43, no. 3, pp. 245–265, 2004.
- C. D. Sherbourne and A. L. Stewart, “The MOS social support survey,” Social Science and Medicine, vol. 32, no. 6, pp. 705–714, 1991.
- Manufacturer's instructions. Millipore Corporation, St. Charles, Mo, USA.
- A. J. Longman, C. J. Braden, and M. H. Mishel, “Side effects burden in women with breast cancer,” Cancer Practice, vol. 4, no. 5, pp. 274–280, 1996.
- O. Minton and P. Stone, “How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature,” Breast Cancer Research and Treatment, vol. 112, no. 1, pp. 5–13, 2008.
- R. F. Steffens, H. R. Wright, M. Y. Hester, and M. A. Andrykowski, “Clinical, demographic, and situational factors linked to distress associated with benign breast biopsy,” Journal of Psychosocial Oncology, vol. 29, no. 1, pp. 35–50, 2011.
- C. E. Mosher and S. Danoff-Burg, “A review of age differences in psychological adjustment to breast cancer,” Journal of Psychosocial Oncology, vol. 23, no. 2-3, pp. 101–114, 2005.